# Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

> **NCT00755417** · PHASE3 · COMPLETED · sponsor: **Depomed** · enrollment: 541 (actual)

## Conditions studied

- Hot Flashes

## Interventions

- **DRUG:** Gabapentin Extended-Release (G-ER) 1200 mg
- **DRUG:** Gabapentin Extended-Release (G-ER) 1800 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00755417
- **Lead sponsor:** Depomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-08
- **Final completion:** 2009-10
- **Target enrollment:** 541 (ACTUAL)
- **Last updated:** 2012-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755417, "Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00755417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*